Wissam Ghusn

Papers

Total Citations

H-Index

About

Wissam Ghusn is a rising investigator at the forefront of metabolic and bariatric medicine, whose work is redefining the landscape of obesity treatment. His primary research focuses on the intersection of advanced endoscopic bariatric therapies, precision medicine, and synergistic pharmacotherapy. Ghusn’s most cited work, "Emerging Trends in Endoscopic Bariatric Therapies: Personalization Through Genomics and Synergistic Pharmacotherapy" (2025), has already garnered significant early attention with 4 citations, signaling its impact as a forward-looking framework. In this seminal paper, he argues for a paradigm shift beyond traditional metabolic surgery, advocating for personalized, minimally invasive endoscopic interventions guided by genomic profiling and combined with next-generation anti-obesity medications. This contribution is notable for bridging the gap between surgical gold standards and non-invasive options, offering a roadmap for tailored, effective care. Ghusn’s research is particularly influential for its emphasis on synergistic pharmacotherapy, positioning him as a key voice in the movement toward holistic, individualized obesity management. His work promises to empower clinicians and researchers with actionable strategies to combat the global obesity epidemic, making him a compelling figure for students and peers alike.